AP003352.1/miR-141-3p axis enhances the proliferation of osteosarcoma by LPAR3

被引:1
|
作者
Yu, Hongde [1 ]
Zhang, Bolun [1 ]
Qi, Lin [1 ]
Han, Jian [1 ]
Guan, Mingyang [1 ]
Li, Jiaze [1 ]
Meng, Qingtao [1 ]
机构
[1] Dalian 3 Peoples Hosp, Dept Orthoped, Dalian, Peoples R China
来源
PEERJ | 2023年 / 11卷
关键词
Bioinformatics; Cell Biology; Molecular Biology; Oncology; Orthopedics; LYSOPHOSPHOLIPID RECEPTORS; PCAT6; PROMOTES; CANCER; MICRORNA; PROGRESSION; MIGRATION; MECHANISM; PROFILES; PATHWAY; CERNA;
D O I
10.7717/peerj.15937
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteosarcoma (OS) is a highly malignant tumor with a poor prognosis and a growing incidence. LncRNAs and microRNAs control the occurrence and development process of osteosarcoma through ceRNA patterns. The LPAR3 gene is important in cancer cell proliferation, apoptosis and disease development. However, the regulatory mechanism of the ceRNA network through which LPAR3 participates in osteosarcoma has not been clarified. Herein, our study demonstrated that the AP003352.1/miR-141-3p axis drives LPAR3 expression to induce the malignant progression of osteosarcoma. First, the expression of LPAR3 is regulated by the changes in AP003352.1 and miR-141-3p. Similar to the ceRNA of miR-141-3p, AP003352.1 regulates the expression of LPAR3 through this mechanism. In addition, the regulation of AP003352.1 in malignant osteosarcoma progression depends to a certain degree on miR-141-3p. Importantly, the AP003352.1/miR-141-3p/LPAR3 axis can better serve as a multi-gene diagnostic marker for osteosarcoma. In conclusion, our research reveals a new ceRNA regulatory network, which provides a novel potential target for the diagnosis and treatment of osteosarcoma.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] LncRNA MALAT1 promotes wound healing via regulating miR-141-3p/ZNF217 axis
    Liang, Zun-Hong
    Pan, Yun-Chuan
    Lin, Shi-Shuai
    Qiu, Zhi-Yang
    Zhang, Zhi
    REGENERATIVE THERAPY, 2020, 15 : 202 - 209
  • [32] DEX Inhibits H/R-induced Cardiomyocyte Ferroptosis by the miR-141-3p/lncRNA TUG1 Axis
    Zhu, Mei
    Yuan, Zhiguo
    Wen, Chuanyun
    Wei, Xiaojia
    THORACIC AND CARDIOVASCULAR SURGEON, 2024,
  • [33] MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression
    Leila Bahmani
    Masoud Baghi
    Maryam Peymani
    Arash Javeri
    Kamran Ghaedi
    Human Cell, 2021, 34 : 1375 - 1387
  • [34] miR-141-3p inhibited BPA-induced proliferation and migration of lung cancer cells through PTGER4
    Ling, Feng
    Xie, Wenbo
    Kui, Xiang
    Cai, Yuyin
    He, Meng
    Ma, Jianqiang
    CYTOTECHNOLOGY, 2025, 77 (01)
  • [35] Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2
    S. J. Tong
    X. Y. Zhang
    H. F. Guo
    J. Yang
    Y. P. Qi
    S. Lu
    Clinical and Translational Oncology, 2021, 23 : 2526 - 2535
  • [36] Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2
    Tong, S. J.
    Zhang, X. Y.
    Guo, H. F.
    Yang, J.
    Qi, Y. P.
    Lu, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (12): : 2526 - 2535
  • [37] ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway
    Wu Xia
    Wen Jie
    Cancer Cell International, 20
  • [38] MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression
    Bahmani, Leila
    Baghi, Masoud
    Peymani, Maryam
    Javeri, Arash
    Ghaedi, Kamran
    HUMAN CELL, 2021, 34 (05) : 1375 - 1387
  • [39] ZEB1-AS1/miR-133a-3p/LPAR3/EGFR axis promotes the progression of thyroid cancer by regulating PI3K/AKT/mTOR pathway
    Xia, Wu
    Jie, Wen
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [40] MiR-141-3p promotes hypoxia-induced autophagy in human placental trophoblast cells
    Luo, Qiqi
    Tian, Yu
    Qu, Guangjin
    Huang, Kun
    Hu, Panpan
    Li, Lianghai
    Luo, Shanshun
    REPRODUCTIVE BIOLOGY, 2023, 23 (01)